Søren Gregersen 300x200.png

Søren Gullaksen, M.D.

Clinical research

soegul@clin.au.dk

Research description

  • Effect of Empagliflozin and Semaglutide on Cardio-Renal Target Organ Damage in patients with type 2 diabetes - A Randomized Trial
  • I’m performing clinical trials to investigate the effects of metformin and/or exercise in T2DM on bone turnover and biomechanical properties along with the effects of alendronate on similar outcomes in T1DM and T2DM.

Find me on